| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP And Chief Of Business Oper
1 company
Pierce Christopher is an EVP And Chief Of Business Oper at Prelude Therapeutics Inc. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $90K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | PRLD Prelude Therapeutics Inc | EVP And Chief Of Business Oper | Sale+OE | 17,000 | $41.68 | $708,492.70 | -34.8% | -64.4% | -80.2% | |
| Apr 29, 2021 | PRLD Prelude Therapeutics Inc | EVP And Chief Of Business Oper | Sale+OE | 3,295 | $40.29 | $132,764.78 | -46.8% | -14.0% | -88.7% | |
| Apr 8, 2021 | PRLD Prelude Therapeutics Inc | EVP And Chief Of Business Oper | Sale+OE | 200 | $40.00 | $8,000.00 | -5.1% | -28.6% | -82.4% | |
| Apr 7, 2021 | PRLD Prelude Therapeutics Inc | EVP And Chief Of Business Oper | Sale+OE | 828 | $40.08 | $33,188.39 | -18.1% | -31.2% | -81.8% | |
| Sep 29, 2020 | PRLD Prelude Therapeutics Inc | EVP And Chief Of Business Oper | Buy | 3,750 | $19.00 | $71,250.00 | New | - | - |